Xometry (NASDAQ:XMTR) Insider Subir Dutt Sells 2,410 Shares of Stock

Xometry, Inc. (NASDAQ:XMTR) insider Subir Dutt sold 2,410 shares of the business’s stock in a transaction dated Thursday, February 26th. The shares were sold at an average price of $43.47, for a total transaction of $104,762.70. Following the completion of the sale, the insider directly owned 88,633 shares of the company’s stock, valued at approximately $3,852,876.51. This trade represents a 2.65% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Subir Dutt also recently made the following trade(s):

• On Monday, February 9th, Subir Dutt sold 2,500 shares of Xometry stock. The stock was sold at an average price of $70.00, for a total transaction of $175,000.00.
• On Monday, January 5th, Subir Dutt sold 3,929 shares of Xometry stock. The shares were sold at an average price of $65.55, for a total transaction of $257,545.95.

Xometry Stock Down 5.9%

Shares of NASDAQ:XMTR opened at $42.57 on Friday. The business’s 50 day moving average is $61.06 and its 200 day moving average is $56.04. The stock has a market cap of $2.18 billion, a P/E ratio of -35.73 and a beta of 0.86. Xometry, Inc. has a 52-week low of $18.59 and a 52-week high of $73.87. The company has a quick ratio of 3.58, a current ratio of 3.76 and a debt-to-equity ratio of 1.18.

Xometry (NASDAQ:XMTR) last issued its earnings results on Tuesday, February 24th. The company reported $0.16 earnings per share for the quarter, beating analysts’ consensus estimates of $0.12 by $0.04. Xometry had a negative return on equity of 5.49% and a negative net margin of 8.99%.The business had revenue of $192.40 million during the quarter, compared to analyst estimates of $183.37 million. During the same period in the previous year, the company posted $0.06 EPS. Xometry’s revenue was up 29.5% on a year-over-year basis. Sell-side analysts predict that Xometry, Inc. will post -0.66 EPS for the current year.

Institutional Trading of Xometry

Large investors have recently added to or reduced their stakes in the stock. Sylebra Capital LLC increased its holdings in shares of Xometry by 9.6% during the 2nd quarter. Sylebra Capital LLC now owns 2,062,157 shares of the company’s stock worth $69,680,000 after buying an additional 180,533 shares during the last quarter. Ameriprise Financial Inc. boosted its holdings in Xometry by 54.2% during the 3rd quarter. Ameriprise Financial Inc. now owns 1,964,909 shares of the company’s stock valued at $107,029,000 after acquiring an additional 690,558 shares during the period. First Trust Advisors LP grew its holdings in shares of Xometry by 9.2% in the fourth quarter. First Trust Advisors LP now owns 1,576,075 shares of the company’s stock valued at $93,729,000 after purchasing an additional 132,792 shares in the last quarter. Baillie Gifford & Co. grew its stake in shares of Xometry by 1.6% in the fourth quarter. Baillie Gifford & Co. now owns 1,306,151 shares of the company’s stock worth $77,677,000 after acquiring an additional 20,901 shares in the last quarter. Finally, Fuller & Thaler Asset Management Inc. purchased a new stake in Xometry during the 4th quarter worth about $76,393,000. 97.31% of the stock is currently owned by hedge funds and other institutional investors.

Xometry News Summary

Here are the key news stories impacting Xometry this week:

• Positive Sentiment: Some Wall Street firms remain constructive — Citi and Wedbush are maintaining buy/outperform stances even after trimming targets, which supports upside conviction among bullish investors. Xometry Price Target Cut to $65.00 by Analysts at Citigroup
• Positive Sentiment: Analysts and media are re‑examining Xometry’s valuation after strong 2025 revenue growth and ahead of a CEO transition — this frames the company as still improving operationally even amid short‑term noise. Assessing Xometry (XMTR) Valuation After Strong 2025 Results And Upcoming CEO Transition
• Positive Sentiment: Management will participate in upcoming investor conferences (including a March 3 fireside chat), giving investors more access to management guidance and the CEO transition story. Xometry to Participate in Upcoming Investor Conferences
• Neutral Sentiment: UBS nudged its target to $55 with a “neutral” rating — a modest move that neither strongly supports nor crushes near‑term momentum. Xometry Given New $55.00 Price Target at UBS Group
• Neutral Sentiment: Royal Bank of Canada trimmed its target to $55 and set “sector perform,” another mixed signal that reduces consensus upside but stops short of a full downgrade. Xometry Price Target Cut to $55.00 by Analysts at Royal Bank Of Canada
• Negative Sentiment: Large, contemporaneous insider sales disclosed Feb. 26: CEO, CFO, President, CTO and other insiders sold multi‑thousand share blocks. Heavy insider selling typically spooks investors and adds downward pressure. (SEC filing for CEO sale.) SEC filing – CEO sale
• Negative Sentiment: Market headlines and analyst downgrades/target cuts triggered selling — several outlets reported shares trading down after the analyst actions, which appears to be a primary driver of intraday weakness. Xometry Trading Down 7.3% After Analyst Downgrade
• Negative Sentiment: Conflicting earnings narratives (some outlets highlighting an EPS beat, others circulating claims of a miss) increase investor uncertainty and short‑term volatility around the company’s Q4/2025 results. Xometry Q4 2025 Earnings Call Transcript

Analyst Ratings Changes

A number of equities research analysts recently weighed in on XMTR shares. JPMorgan Chase & Co. lifted their target price on Xometry from $55.00 to $70.00 and gave the company an “overweight” rating in a research note on Wednesday, November 5th. William Blair reissued an “outperform” rating on shares of Xometry in a report on Tuesday. UBS Group raised their target price on shares of Xometry from $54.00 to $55.00 and gave the stock a “neutral” rating in a report on Wednesday. Weiss Ratings reissued a “sell (e+)” rating on shares of Xometry in a report on Wednesday, January 21st. Finally, Zacks Research downgraded Xometry from a “hold” rating to a “strong sell” rating in a research note on Friday, January 30th. Five research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $62.00.

About Xometry

Xometry, Inc (NASDAQ: XMTR) operates a technology-driven marketplace that connects businesses with on-demand manufacturing capacity across a wide array of processes. Through its proprietary Instant Quoting Engine and Xometry Platform, the company streamlines sourcing for CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other custom manufacturing services. By aggregating a network of thousands of vetted suppliers, Xometry offers rapid lead times, transparent pricing and real-time order tracking to customers in sectors ranging from automotive and aerospace to medical devices and industrial equipment.

Since its founding in 2013 and headquarters in Rockville, Maryland, Xometry has expanded its geographic reach to serve customers in North America, Europe and beyond.